Fig. 2From: First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot studyPatient 1 underwent gross total resection and radiochemotherapy. [18F]FET-PET/MRI did not show relevant residual tumor tissue. No relevant leakage was detected. Fourty-eight hours after application of the first cycle of iRIT, whole body imaging showed uptake in the resection cavity and in the kidneysBack to article page